vs

Side-by-side financial comparison of COLONY BANKCORP INC (CBAN) and CODEXIS, INC. (CDXS). Click either name above to swap in a different company.

COLONY BANKCORP INC is the larger business by last-quarter revenue ($39.9M vs $38.9M, roughly 1.0× CODEXIS, INC.). CODEXIS, INC. runs the higher net margin — 24.7% vs 20.6%, a 4.1% gap on every dollar of revenue. Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs 19.6%).

Colony Bankcorp Inc is a US-based bank holding company that operates Colony Bank. It provides a full suite of personal and commercial banking services including deposit accounts, consumer and business loans, mortgage services, and wealth management solutions, primarily serving retail customers and small-to-medium enterprises across the state of Georgia.

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

CBAN vs CDXS — Head-to-Head

Bigger by revenue
CBAN
CBAN
1.0× larger
CBAN
$39.9M
$38.9M
CDXS
Higher net margin
CDXS
CDXS
4.1% more per $
CDXS
24.7%
20.6%
CBAN
Faster 2-yr revenue CAGR
CDXS
CDXS
Annualised
CDXS
51.0%
19.6%
CBAN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CBAN
CBAN
CDXS
CDXS
Revenue
$39.9M
$38.9M
Net Profit
$8.2M
$9.6M
Gross Margin
94.8%
Operating Margin
27.1%
Net Margin
20.6%
24.7%
Revenue YoY
81.3%
Net Profit YoY
24.1%
192.5%
EPS (diluted)
$0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBAN
CBAN
CDXS
CDXS
Q1 26
$39.9M
Q4 25
$36.9M
$38.9M
Q3 25
$32.8M
$8.6M
Q2 25
$32.5M
$15.3M
Q1 25
$30.0M
$7.5M
Q4 24
$30.8M
$21.5M
Q3 24
$28.6M
$12.8M
Q2 24
$27.9M
$8.0M
Net Profit
CBAN
CBAN
CDXS
CDXS
Q1 26
$8.2M
Q4 25
$9.6M
Q3 25
$5.8M
$-19.6M
Q2 25
$8.0M
$-13.3M
Q1 25
$6.6M
$-20.7M
Q4 24
$-10.4M
Q3 24
$5.6M
$-20.6M
Q2 24
$5.5M
$-22.8M
Gross Margin
CBAN
CBAN
CDXS
CDXS
Q1 26
Q4 25
94.8%
Q3 25
71.3%
Q2 25
86.3%
Q1 25
63.8%
Q4 24
83.0%
Q3 24
66.4%
Q2 24
56.6%
Operating Margin
CBAN
CBAN
CDXS
CDXS
Q1 26
Q4 25
25.9%
27.1%
Q3 25
22.2%
-220.3%
Q2 25
30.9%
-83.9%
Q1 25
27.6%
-271.6%
Q4 24
28.8%
-34.2%
Q3 24
24.6%
-129.0%
Q2 24
24.8%
-284.9%
Net Margin
CBAN
CBAN
CDXS
CDXS
Q1 26
20.6%
Q4 25
24.7%
Q3 25
17.7%
-228.1%
Q2 25
24.6%
-86.6%
Q1 25
22.0%
-274.3%
Q4 24
-48.4%
Q3 24
19.7%
-160.8%
Q2 24
19.6%
-285.2%
EPS (diluted)
CBAN
CBAN
CDXS
CDXS
Q1 26
Q4 25
$0.42
$0.13
Q3 25
$0.33
$-0.22
Q2 25
$0.46
$-0.16
Q1 25
$0.38
$-0.25
Q4 24
$0.43
$-0.12
Q3 24
$0.32
$-0.29
Q2 24
$0.31
$-0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBAN
CBAN
CDXS
CDXS
Cash + ST InvestmentsLiquidity on hand
$295.8M
$78.2M
Total DebtLower is stronger
$40.1M
Stockholders' EquityBook value
$380.4M
$50.5M
Total Assets
$3.7B
$147.8M
Debt / EquityLower = less leverage
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBAN
CBAN
CDXS
CDXS
Q1 26
$295.8M
Q4 25
$78.2M
Q3 25
$58.7M
Q2 25
$66.3M
Q1 25
$59.8M
Q4 24
$73.5M
Q3 24
$90.3M
Q2 24
$73.2M
Total Debt
CBAN
CBAN
CDXS
CDXS
Q1 26
Q4 25
$258.1M
$40.1M
Q3 25
$39.7M
Q2 25
$39.4M
Q1 25
$29.2M
Q4 24
$248.0M
$28.9M
Q3 24
$28.6M
Q2 24
$28.4M
Stockholders' Equity
CBAN
CBAN
CDXS
CDXS
Q1 26
$380.4M
Q4 25
$375.9M
$50.5M
Q3 25
$302.3M
$38.5M
Q2 25
$293.9M
$55.6M
Q1 25
$286.9M
$49.6M
Q4 24
$278.7M
$66.9M
Q3 24
$276.1M
$73.4M
Q2 24
$264.7M
$61.4M
Total Assets
CBAN
CBAN
CDXS
CDXS
Q1 26
$3.7B
Q4 25
$3.7B
$147.8M
Q3 25
$3.2B
$124.0M
Q2 25
$3.1B
$138.2M
Q1 25
$3.2B
$128.9M
Q4 24
$3.1B
$149.0M
Q3 24
$3.1B
$148.2M
Q2 24
$3.0B
$132.0M
Debt / Equity
CBAN
CBAN
CDXS
CDXS
Q1 26
Q4 25
0.69×
0.79×
Q3 25
1.03×
Q2 25
0.71×
Q1 25
0.59×
Q4 24
0.89×
0.43×
Q3 24
0.39×
Q2 24
0.46×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBAN
CBAN
CDXS
CDXS
Operating Cash FlowLast quarter
$20.1M
Free Cash FlowOCF − Capex
$19.6M
FCF MarginFCF / Revenue
50.3%
Capex IntensityCapex / Revenue
1.3%
Cash ConversionOCF / Net Profit
2.09×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBAN
CBAN
CDXS
CDXS
Q1 26
Q4 25
$-5.5M
$20.1M
Q3 25
$14.4M
$-7.7M
Q2 25
$15.8M
$-18.0M
Q1 25
$17.9M
$-13.8M
Q4 24
$23.4M
$-16.5M
Q3 24
$20.5M
$-13.0M
Q2 24
$1.1M
$-12.2M
Free Cash Flow
CBAN
CBAN
CDXS
CDXS
Q1 26
Q4 25
$-6.9M
$19.6M
Q3 25
$14.1M
$-7.9M
Q2 25
$15.8M
$-20.5M
Q1 25
$17.6M
$-15.1M
Q4 24
$22.3M
$-18.2M
Q3 24
$20.2M
$-14.0M
Q2 24
$990.0K
$-12.6M
FCF Margin
CBAN
CBAN
CDXS
CDXS
Q1 26
Q4 25
-18.7%
50.3%
Q3 25
42.9%
-91.7%
Q2 25
48.5%
-133.6%
Q1 25
58.7%
-199.6%
Q4 24
72.5%
-85.0%
Q3 24
70.6%
-109.0%
Q2 24
3.5%
-157.5%
Capex Intensity
CBAN
CBAN
CDXS
CDXS
Q1 26
Q4 25
3.7%
1.3%
Q3 25
1.1%
2.1%
Q2 25
0.3%
16.4%
Q1 25
1.2%
16.7%
Q4 24
3.5%
8.3%
Q3 24
1.0%
7.8%
Q2 24
0.5%
5.0%
Cash Conversion
CBAN
CBAN
CDXS
CDXS
Q1 26
Q4 25
2.09×
Q3 25
2.48×
Q2 25
1.99×
Q1 25
2.71×
Q4 24
Q3 24
3.64×
Q2 24
0.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBAN
CBAN

Net Interest Income$29.2M73%
Noninterest Income$10.7M27%

CDXS
CDXS

Segment breakdown not available.

Related Comparisons